Full Length Research Paper
References
Beaudeux JL, Durand G (2011). Biochimie médicale: Marqueurs actuels et perspectives. Paris 2th ed. Lavoisier pp. 211-241. |
|
Brown C, Awisi B, Asmah H, Dzudzor B, Ghansah A (2013). Association between haptoglobin genotype polymorphism and type two (2) diabetes in Accra, Ghana. American Journal of Biomedical and Life Sciences 1(4):103-109. |
|
Dahan I, Farber E, Thauho N, Nakhoul N, Francis A, Awawde M, Levy AP, Kim-Shapiro DB, Basu S, Nakhoul F (2015). Interaction between the Haptoglobin 2 Phenotype and Diabetes Mellitus on Systolic Pulmonary Arterial Pressure and Nitric Oxide Bioavailability in Hemodialysis Patients. Journal of Diabetes Research. |
|
Dalan R, Liew H, Goh LL, Gao X, Chew DEK, Boehm BO, Leow MKS (2016). The haptoglobin 2-2 genotype is associated with inflammation and carotid artery intima-media thickness. Diabetes and Vascular Disease Research 13(5):373-376. |
|
Demnati C, Khiari K, Hadj Ali I, M'Chirgui N, Lakhoua Y (2010). Fréquence de la microangiopathie chez les diabétiques de type 1 et de type 2. Diabetes and Metabolism 36(1):54-55. |
|
Diabetes Atlas (2017). International Diabete Federation. Available at: |
|
Djrolo F, Houinato D, Gbary A, Akoha R, Djigbénoudé O, Sègnon J (2012). Prévalence du diabètesucrédans la population adulte à Cotonou, Bénin. Médecine des maladies Métaboliques 6(2):167-169. |
|
Drabo PY, Kabore J, Lengani A, Ilboudo PD (1996). Diabetes mellitus at the National Hospital Center of Ouagadougou (Burkina Faso). Le Bulletin de la Société de Pathologie Exotique 89(3):185-190. |
|
Giugliano D, Ceriello A, Paolisso G (1996). Oxidative stress and diabetic vascular complications. Diabetes Care 19(3):257-267. |
|
Guèye PM (2007). Phénotypes majeurs de l'haptoglobine humaine et stress oxidant induit par l'hémoglobine extra-érythrocytaire sur le globule rouge. [thèse de Doctorat]. Strasbourg, France: Louis Pasteur University. |
|
Gurler B, Vural H, Yilmaz N, Oguz H, Satici A, Aksoy N (2000). The role of oxidative stress in diabetic retinopathy. Eye 14:730-735. |
|
Harris H, Robson EB, Siniscalco M (1959). Genetics of the Plasma ProteinVariants Ciba Foundation Sympos. Biochemistry of Human Genetics 151:177. |
|
Holme I, Astveit AH, Hammar N, Jungner I, Walldius G (2009). Haptoglobin and Risk of Myocardial Infarction, Stroke, and Congestive Heart Failure in 342,125 Men and Wome in the Apolipoprotein mortality. Annals of Medicine 41(7):522-32. |
|
Koch W, Latz W, Eichinger M, Roguin A, Levy AP, Schomig A, Kastrati A (2002). Genotyping of the Common HaptoglobinHp 1/2 Polymorphism Based on PCR. Clinical Chemistry 48(9):1377 1382. |
|
Levy AP, Roguin A, Hochberg I, Herer P, Marsh S, Nakhoul FM, Skorecki K (2000). Haptoglobin phenotype and vascular complications in patients with diabetes. New England Journal of Medicine 343(13):969-970. |
|
Melamed-Frank M, Lache O, Enav BI, Szafranek T, Levy NS, Ricklis RM, Levy AP (2001). Structure-function analysis of the antioxidant properties of haptoglobin. Blood 98(13):3693-3698. |
|
Millogo GRC, Yaméogo C, Samandoulougou A, Yaméogo NV, Kologo KJ, Toguyeni JY, Zabsonré P (2015). Diabète en milieu urbain de Ouagadougou au Burkina Faso: profil épidémiologique et niveau de perception de la population adulte. The Pan African Medical Journal 20(146):1-4. |
|
Moullec J, Fine JM, Linhard J (1961). Les groups d'haptoglobine, moyen d'étude des populations humaines. Bulletins et Mémoires de la Société d'anthropologie de Paris 2(1):109 124. |
|
Nakhoul FM, Marsh S, Hochberg I, Leibu R, Miller B (2000). Haptoglobin genotype as a risk factor for diabetic retinopathy. JAMA 284(10):1244-1245. |
|
Nakhoul F, Zoabi R, Kanter Y, Zoabi M, Skorecki K, Hochberg I, Leibu R, Miller B, Levy AP (2001). Haptoglobin phenotype and diabetic nephropathy. Diabetologia 44(5):602-604. |
|
Ndour-Mbaye M, Sarr A, Diop SN, Leye A, Diedhiou D, Ka-Cissé MS, Kane AM, Paye M, Ndiaye NB (2011). DiabCareSenegal: uneenquêtesur la prise en charge du diabète au Sénégal. Médecine des maladies Métaboliques 5(1):85-89. |
|
Szafranek T, Marsh S, Levy AP (2002). Haptoglobin: A major susceptibility gene for diabetic vascular complications. Experimental and Clinical Cardiology 7:113-119. |
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0